Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Transaction in Own Shares and Total Voting Rights

23rd Apr 2026 13:44

RNS Number : 7102B
Fortis Frontier PLC
23 April 2026
 

 

Fortis Frontier PLC

("Fortis Frontier" or the "Company")

 

Transaction in Own Shares and Total Voting Rights

 

Fortis Frontier PLC (AIM: FORF), an AIM Rule 15 cash shell (formerly MyHealthChecked PLC), announces that on 23 April 2026, pursuant to the authority approved by shareholders at the Company's Annual General Meeting of 31 July 2025, the Company purchased 1,234,442 ordinary shares of 1.5 pence each ("Ordinary Shares") at a price of 8.6p per share, representing approximately 2.42% of the Company's issued share capital. 

 

Total Voting Rights

The Company intends that the purchased Ordinary Shares will be cancelled as soon as practical. Following cancellation of the purchased Ordinary Shares, the Company's total number of ordinary shares in issue shall be 49,866,385 Ordinary Shares.

 

The above figure of 49,866,385 Ordinary Shares should be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.

 

For further information contact:

 

Fortis Frontier PLC

www.fortisfrontierplc-ir.com

Adam Reynolds, Executive Chairman

via Walbrook PR

SPARK Advisory Partners Limited (NOMAD)

Tel: +44 (0)20 3368 3550

Neil Baldwin / Dillon Wall

Singer Capital Markets (Broker)

Tel: +44 (0)20 7496 3000

James Serjeant / Russell Cook / Amber Higgs

Walbrook PR Ltd (Media & IR)

Tel: +44 (0)20 7933 8780 or [email protected]

Paul McManus / Alice Woodings

Mob: +44 (0)7980 541 893 / +44(0)7407 804 654

 

About Fortis Frontier PLC

On 10 November 2025 MyHealthChecked PLC completed the disposal of its trading subsidiary, Concepta Diagnostics Limited, becoming an AIM Rule 15 Cash Shell, as defined in the AIM Rules for Companies. On the same day the Company changed its name to Fortis Frontier PLC. The Board is now carefully considering the strategic options available to it in order to maximise shareholder value.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
POSPPUMWCUPQGPW

Related Shares:

Fortis Frontier
FTSE 100 Latest
Value10,379.08
Change-77.93